From: Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
Sub-group
Number of patients
5-year DMFS (%)
95% CI
All patients
421
87.8
84.1–91.5
2–3 Intermediate risk factors
104
93.7
88.2–99.2
1 High risk factor
225
88.0
83.1–92.9
2–3 High risk factors
92
81.2
71.6–90.8
V High Risk
126
78.4
70.8–86.0